Close Menu

NEW YORK — IncellDx said on Tuesday that it has signed an agreement to validate and launch its COVID-19 cytokine storm panel with MD Biosciences.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.